Integral Diagnostics Limited
ITGDF
$2.06
$0.687450.00%
OTC PK
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | 82.39M | 84.72M | 78.57M | 78.40M | 75.35M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 82.39M | 84.72M | 78.57M | 78.40M | 75.35M |
Cost of Revenue | 57.02M | 58.63M | 53.12M | 53.01M | 51.17M |
Gross Profit | 25.37M | 26.08M | 25.44M | 25.39M | 24.19M |
SG&A Expenses | 4.79M | 4.92M | 4.30M | 4.29M | 4.49M |
Depreciation & Amortization | 7.66M | 7.88M | 7.91M | 7.90M | 7.44M |
Other Operating Expenses | 3.56M | 3.67M | 811.90K | 810.20K | 3.62M |
Total Operating Expenses | 75.75M | 77.89M | 71.23M | 71.09M | 69.05M |
Operating Income | 6.64M | 6.82M | 7.33M | 7.32M | 6.31M |
Income Before Tax | 125.40K | 129.00K | 2.84M | 2.84M | -21.43M |
Income Tax Expenses | 254.50K | 261.70K | 848.40K | 846.70K | 322.30K |
Earnings from Continuing Operations | -129.00K | -132.70K | 2.00M | 1.99M | -21.75M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -129.00K | -132.70K | 2.00M | 1.99M | -21.75M |
EBIT | 6.64M | 6.82M | 7.33M | 7.32M | 6.31M |
EBITDA | 11.46M | 11.78M | 12.25M | 12.23M | 11.02M |
EPS Basic | 0.00 | 0.00 | 0.01 | 0.01 | -0.09 |
Normalized Basic EPS | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
EPS Diluted | 0.00 | 0.00 | 0.01 | 0.01 | -0.09 |
Normalized Diluted EPS | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
Average Basic Shares Outstanding | 247.50M | 247.50M | 233.74M | 233.74M | 233.25M |
Average Diluted Shares Outstanding | 247.50M | 247.50M | 239.41M | 239.41M | 233.25M |
Dividend Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Payout Ratio | -1,924.49% | -1,924.49% | 102.46% | 102.46% | -11.41% |